WO2010036939A3 - A system for synergistic expression of multiple small functional rna elements - Google Patents
A system for synergistic expression of multiple small functional rna elements Download PDFInfo
- Publication number
- WO2010036939A3 WO2010036939A3 PCT/US2009/058451 US2009058451W WO2010036939A3 WO 2010036939 A3 WO2010036939 A3 WO 2010036939A3 US 2009058451 W US2009058451 W US 2009058451W WO 2010036939 A3 WO2010036939 A3 WO 2010036939A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- multiple small
- functional rna
- rna elements
- small functional
- synergistic expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
- C12N2330/51—Specially adapted vectors
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates in general to microRNAs (miRNAs). More specifically, the invention relates to expression vectors comprising multiple miRNAs or families and clusters capable of targeting multiple oncogenic pathways.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/296,121 US20120208267A1 (en) | 2008-08-07 | 2011-11-14 | System for Synergistic Expression of Multiple Small Functional RNA Elements |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10064608P | 2008-09-26 | 2008-09-26 | |
US61/100,646 | 2008-09-26 | ||
USPCT/US2009/053203 | 2009-08-07 | ||
PCT/US2009/053203 WO2010017510A1 (en) | 2008-08-07 | 2009-08-07 | A system for synergistic expression of multiple small functional rna elements |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/053203 Continuation-In-Part WO2010017510A1 (en) | 2008-08-07 | 2009-08-07 | A system for synergistic expression of multiple small functional rna elements |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US201113072576A Continuation | 2008-08-07 | 2011-03-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010036939A2 WO2010036939A2 (en) | 2010-04-01 |
WO2010036939A3 true WO2010036939A3 (en) | 2010-06-17 |
Family
ID=42060410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/058451 WO2010036939A2 (en) | 2008-08-07 | 2009-09-25 | A system for synergistic expression of multiple small functional rna elements |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010036939A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5587777B2 (en) | 2007-07-31 | 2014-09-10 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | MicroRNA family modulating fibrosis and uses thereof |
BRPI0818901A2 (en) | 2007-11-09 | 2015-05-12 | Univ Texas | Mir-15 family micro-rna modulate cardiomyocyte survival and cardiac repair |
EP2582399A4 (en) * | 2010-06-16 | 2015-04-15 | Minerva Biotechnologies Corp | Reprogramming cancer cells |
GB201117482D0 (en) * | 2011-10-11 | 2011-11-23 | Univ Dundee | Targetiing of miRNA precursors |
US20150140591A1 (en) | 2012-06-06 | 2015-05-21 | Boehringer Ingelheim International Gmbh | CELL ENGINEERING USING RNAs |
US9163235B2 (en) | 2012-06-21 | 2015-10-20 | MiRagen Therapeutics, Inc. | Inhibitors of the miR-15 family of micro-RNAs |
EP3788141A4 (en) * | 2018-04-30 | 2023-03-08 | The Brigham and Women's Hospital, Inc. | Compositions and therapeutic methods of microrna gene delivery |
KR102312393B1 (en) * | 2021-04-09 | 2021-10-15 | 쎄니테크코리아(주) | Composition for disinfection and sterilization comprising natural extracts |
CN114010786A (en) * | 2021-11-25 | 2022-02-08 | 江南大学 | Method for treating triple negative breast cancer by double antisense nucleic acid synergistic photodynamic |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007033023A2 (en) * | 2005-09-12 | 2007-03-22 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
WO2008068046A1 (en) * | 2006-12-05 | 2008-06-12 | Istituto Superiore di Sanità | Micro rna targeting aml1 |
-
2009
- 2009-09-25 WO PCT/US2009/058451 patent/WO2010036939A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007033023A2 (en) * | 2005-09-12 | 2007-03-22 | The Ohio State University Research Foundation | Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
WO2008068046A1 (en) * | 2006-12-05 | 2008-06-12 | Istituto Superiore di Sanità | Micro rna targeting aml1 |
Non-Patent Citations (4)
Title |
---|
CIMMINO AMELIA ET AL: "miR-15 and miR-16 induce apoptosis by targeting BCL2", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 102, no. 39, 27 September 2005 (2005-09-27), pages 13944 - 13949, XP002484308, ISSN: 0027-8424 * |
LE SAGE CARLOS ET AL: "Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 26, no. 15, August 2007 (2007-08-01), pages 3699 - 3708, XP002550796, ISSN: 0261-4189 * |
VELU CHINAVENMENI S ET AL: "Gfi1 regulates miR-21 and miR-196b to control myelopoiesis", BLOOD, vol. 113, no. 19, May 2009 (2009-05-01), pages 4720 - 4728, XP002550795, ISSN: 0006-4971 * |
VOORHOEVE P MATHIJS ET AL: "A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors", CELL, vol. 124, no. 6, March 2006 (2006-03-01), pages 1169 - 1181, XP002550797, ISSN: 0092-8674 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010036939A2 (en) | 2010-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010036939A3 (en) | A system for synergistic expression of multiple small functional rna elements | |
WO2011139699A3 (en) | 5' modified nucleosides and oligomeric compounds prepared therefrom | |
HK1150857A1 (en) | Microrna (mirna) mir-21 for diagnostic and therapeutic purposes | |
MX315135B (en) | 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors | |
WO2008091703A3 (en) | Chemically modified oligonucleotides for use in modulating micro rna and uses thereof | |
IL208638A0 (en) | 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors | |
HK1189885A1 (en) | 1,3-disubstituted-4-pheny-3,4,5,6-tetrahydro-2h,1h-[1,4] bipyridinyl- 2-ones 13--4--3456--2h1h-[14]-2- | |
GB0813603D0 (en) | Ventricular assist system | |
EP1904110A4 (en) | Targeting cells with altered microrna expression | |
WO2009076400A3 (en) | Compositions and methods for inhibiting expression of factor vii gene | |
IL209193A0 (en) | Bronchial catheters, systems comprising the same and uses thereof | |
AP2011005929A0 (en) | Substituted nucleoside and nucleotide analogs. | |
EP2241621A4 (en) | Modified glucose dehydrogenase gene | |
IL208374A0 (en) | Double-stranded lipid-modified rna having high rna interference effect | |
GB0704234D0 (en) | Improvements relating to spreadsheet systems | |
IL274522A (en) | 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors | |
IL211498A (en) | Stable poxvirus vectors comprising two nucleotide seqences, method for generating them and uses thereof | |
WO2012079046A3 (en) | Compositions and methods for inhibiting expression of klf-1 and bcl11a genes | |
EP2896696A3 (en) | Modifications for antisense compounds | |
EP2215035A4 (en) | Bisulphite treatment of rna | |
WO2009006446A3 (en) | Methods for cloning small rna species | |
EP2118297A4 (en) | Generation of nucleic acid molecules | |
WO2010006342A3 (en) | Compositions and methods for inhibiting expression of gsk-3 genes | |
ZA201007254B (en) | (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity | |
IL209403A0 (en) | Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09813870 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09813870 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |